Trial Outcomes & Findings for Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy (NCT NCT00888979)
NCT ID: NCT00888979
Last Updated: 2017-01-09
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
10 participants
Primary outcome timeframe
Baseline to 4 weeks
Results posted on
2017-01-09
Participant Flow
Participant milestones
| Measure |
Nicotrol Inhaler With Behavioral Counseling
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
|
|---|---|
|
Overall Study
STARTED
|
10
|
|
Overall Study
Received the Inhaler/Counseling
|
8
|
|
Overall Study
COMPLETED
|
6
|
|
Overall Study
NOT COMPLETED
|
4
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy
Baseline characteristics by cohort
| Measure |
Nicotrol Inhaler With Behavioral Counseling
n=8 Participants
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
8 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
|
Age, Continuous
|
26 years
n=99 Participants
|
|
Gender
Female
|
8 Participants
n=99 Participants
|
|
Gender
Male
|
0 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
8 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: Baseline to 4 weeksOutcome measures
| Measure |
Nicotrol Inhaler With Behavioral Counseling
n=6 Participants
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
|
|---|---|
|
Number of Days of Inhaler Use
|
26.4 days
Standard Deviation 3
|
SECONDARY outcome
Timeframe: Baseline to 4 weeksOutcome measures
| Measure |
Nicotrol Inhaler With Behavioral Counseling
n=6 Participants
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
|
|---|---|
|
Cartridge Use
|
2 cartridges per day
Standard Deviation 1.5
|
SECONDARY outcome
Timeframe: Baseline to 4 weeksOutcome measures
| Measure |
Nicotrol Inhaler With Behavioral Counseling
n=6 Participants
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
|
|---|---|
|
Change in Number of Cigarettes Used Per Day From Baseline to 4 Weeks.
|
-5.7 reduction in number of CPD
Standard Deviation 2.3
|
Adverse Events
Nicotrol Inhaler With Behavioral Counseling
Serious events: 1 serious events
Other events: 4 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Nicotrol Inhaler With Behavioral Counseling
n=8 participants at risk
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
|
|---|---|
|
Pregnancy, puerperium and perinatal conditions
preterm premature rupture of membranes
|
12.5%
1/8 • Number of events 1 • Baseline to delivery, up to 27 weeks)
|
Other adverse events
| Measure |
Nicotrol Inhaler With Behavioral Counseling
n=8 participants at risk
Nicotrol Inhaler: 10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern
|
|---|---|
|
Gastrointestinal disorders
Nausea
|
25.0%
2/8 • Number of events 2 • Baseline to delivery, up to 27 weeks)
|
|
Nervous system disorders
Headache
|
25.0%
2/8 • Number of events 3 • Baseline to delivery, up to 27 weeks)
|
|
General disorders
Lightheadedness
|
12.5%
1/8 • Number of events 1 • Baseline to delivery, up to 27 weeks)
|
|
Gastrointestinal disorders
heartburn
|
12.5%
1/8 • Number of events 1 • Baseline to delivery, up to 27 weeks)
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place